Detalhe da pesquisa
1.
Enhancement of capecitabine efficacy by oxaliplatin in human colorectal and gastric cancer xenografts.
Oncol Rep
; 18(4): 775-8, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17786335
2.
Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts.
Oncol Rep
; 27(2): 303-10, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22076074
3.
Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
Clin Exp Metastasis
; 28(7): 649-59, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21688034
4.
Schedule-dependent antitumor activity of the combination with erlotinib and docetaxel in human non-small cell lung cancer cells with EGFR mutation, KRAS mutation or both wild-type EGFR and KRAS.
Oncol Rep
; 24(5): 1141-6, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20878103
5.
Antitumor activity of erlotinib in combination with gemcitabine in in vitro and in vivo models of KRAS-mutated pancreatic cancers.
Oncol Lett
; 1(2): 231-235, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22966286
6.
Effect of erythropoietin on human tumor growth in xenograft models.
Mol Med Rep
; 3(1): 95-101, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21472206